✦ LIBER ✦

185. Safety of Equine F(ab’)2 Antivenom for Scorpion Envenomation: Results of Prospective Clinical Trials

✍ Scribed by Leslie Boyer; Michelle Ruha; Jan Degan; Jody Mallie; Alejandro Alagón

Book ID: 113934452
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 203 KB
Volume: 60
Category: Article
ISSN: 0041-0101
DOI: 10.1016/j.toxicon.2012.04.186

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of intravenous equine F(ab')2: In

Safety of intravenous equine F(ab')2: Insights following clinical trials involving 1534 recipients of scorpion antivenom

✍ Boyer, Leslie; Degan, Janice; Ruha, Anne-Michelle; Mallie, Joanne; Mangin, Emman 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 416 KB

Clinical safety of a polyvalent F(ab′)2

Clinical safety of a polyvalent F(ab′)2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon

✍ J.-P. Chippaux; J. Lang; S.Amadi Eddine; P. Fagot; V. Rage; J.-C. Peyrieux; V. L 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 880 KB

A large-scale clinical trial was conducted, according to World Health Organization Good Clinical Practice guidelines, in 7 centres in north Cameroon to determine the safety and efficacy of a polyvalent antivenom composed of purified F(ab')z. This study included 223 patients presenting clinically wit

Clinical evaluation of a new polyvalent

Clinical evaluation of a new polyvalent and purified equine F(ab′)2 antivenom (Viperfar8) for the treatment of human envenomations caused by European vipers

✍ L. de Haro; J. Lang; R. Bedry; D. Guelon; P. Harry; SVE Study Investigators; F.M 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 217 KB

Safety and efficacy of the M2A patency c

Safety and efficacy of the M2A patency capsule for diagnosis of critical intestinal patency: Results of a prospective clinical trial

✍ Rupa Banerjee; Prem Bhargav; Praveen Reddy; Rajesh Gupta; Sandeep Lakhtakia; Man 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

A prospective, randomized, pragmatic, he

A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results

✍ J.-P. Raynauld; G.W. Torrance; P.A. Band; C.H. Goldsmith; P. Tugwell; V. Walker; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 335 KB

A prospective, randomized, pragmatic, he

✍ J.-P. Raynauld; G.W. Torrance; P.A. Band; C.H. Goldsmith; P. Tugwell; V. Walker; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 335 KB

## Objective: First, to assess the clinical effectiveness of hylan g-f 20 in an appropriate care treatment regimen (as defined by the american college of rheumatology (acr) 1995 guidelines) as measured by validated disease-specific outcomes and health-related quality of life endpoints for patients